SCHEMBL19212427

SCHEMBL19212427

CC(=O)SCC(=O)NCCc1ccc(N2CCN(C(C)(C)C)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ CNR1 P21554 3/20 0.40
▸ CTSL P07711 2/20 0.39
▸ CTSS P25774 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ HTR2A P28223 3/20 0.38
▸ HTR2C P28335 3/20 0.38
▸ HTR2B P41595 3/20 0.38
▸ CTSK P43235 2/20 0.37
▸ ESRRB O95718 1/20 0.37
▸ ESRRG P62508 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212298 0.85 TAAR1 (0.49) TAAR1SMN1; SMN2LMNACNR1MEN1
SCHEMBL22957596 0.84 SMN1; SMN2 (0.53) TAAR1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL24422225 0.72 CHKA (0.44) CTSLCTSSCTSBDRD2MAPT
SCHEMBL27458962 0.70 SMN1; SMN2 (0.48) TAAR1SMN1; SMN2LMNACNR1MEN1
SCHEMBL10282609 0.69 MEN1 (0.62) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL24422230 0.68 CHKA (0.58) SMN1; SMN2CTSLCTSSCTSBCTSK
SCHEMBL19212452 0.67 SMN1; SMN2 (0.57) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL23928222 0.67 KMT2A (0.53) CNR1CTSLCTSSKMT2AHTR2A
SCHEMBL12631526 0.67 KMT2A (0.58) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL23291239 0.67 NAMPT (0.55) SMN1; SMN2CTSLCTSSMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 — — EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 — — WO disclosed
Send feedback